Cargando…

Short course of dutasteride in treatment of a refractory category IIIB chronic prostatitis (A placebo-controlled study)

OBJECTIVE: To evaluate the short-term efficacy of Dutasteride in the management of chronic prostatitis (CP)/chronic pelvic pain syndrome. MATERIALS AND METHODS: A randomized placebo-controlled double-blind study was conducted that including 50 patients diagnosed with CP based on the presence of pelv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Higazy, Ahmed, Shorbagy, A.A., Shabayek, Mohamed, Radwan, Ahmed, Halim, George N., Osman, Dana, Osman, Tarek
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Asian Pacific Prostate Society 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9747604/ https://www.ncbi.nlm.nih.gov/pubmed/36570649 http://dx.doi.org/10.1016/j.prnil.2022.06.002

Ejemplares similares

Surgical management of a locally invasive renal cell carcinoma in an ectopic pelvic kidney
por: Higazy, A., et al.
Publicado: (2019)

Evaluation of the risk factors associated with the development of post-transurethral resection of the prostate persistent bacteriuria
por: Osman, Tarek, et al.
Publicado: (2017)

Update on the use of dutasteride in the management of benign prostatic hypertrophy
por: Miller, Joe, et al.
Publicado: (2007)

Characteristics of prostate biopsy in patients under the dutasteride treatment
por: Obinata, Daisuke, et al.
Publicado: (2022)

Prostatic artery embolization versus transurethral resection of the prostate in management of benign prostatic hyperplasia
por: Radwan, Ahmed, et al.
Publicado: (2020)

The Effect of Tamsulosin, Dutasteride Monotherapy and Tamsulosin-Dutasteride Combination on Prostate Smooth Muscle Contractility in BPH Model Wistar Strain Rattus Novergicus
por: Daryanto, Besut, et al.
Publicado: (2023)

Combination therapy with dutasteride and tamsulosin for the treatment of symptomatic enlarged prostate
por: Miller, J, et al.
Publicado: (2009)

The Different Reduction Rate of Prostate-Specific Antigen in Dutasteride and Finasteride
por: Choi, Yong Hyeuk, et al.
Publicado: (2010)

Response of prostate cancer to addition of dutasteride after progression on abiraterone
por: Lian, Jian-Po, et al.
Publicado: (2020)

Mesotherapy with Dutasteride in the Treatment of Androgenetic Alopecia
por: Saceda-Corralo, David, et al.
Publicado: (2017)

Surgical blood loss during holmium laser enucleation of the prostate (HoLEP) is not affected by short-term pretreatment with dutasteride: a double-blind placebo-controlled trial on prostate vascularity
por: Busetto, Gian Maria, et al.
Publicado: (2020)

Impact of short‐term Dutasteride treatment on prostate‐specific membrane antigen expression in a mouse xenograft model
por: Kranzbühler, Benedikt, et al.
Publicado: (2021)

Economic Evaluation for Benign Prostatic Hyperplasia in Iran: Surgical Treatment or Dutasteride
por: Khedmati, Jamaleddin, et al.
Publicado: (2021)

The Effect of Two Weeks of Treatment with Dutasteride on Bleeding after Transurethral Resection of the Prostate
por: Kim, Kyu Shik, et al.
Publicado: (2015)

Long-term clinical course of a patient with mucopolysaccharidosis type IIIB
por: Kim, Ja Hye, et al.
Publicado: (2016)

Preventive and Therapeutic Efficacy of Finasteride and Dutasteride in TRAMP Mice
por: Opoku-Acheampong, Alexander B., et al.
Publicado: (2013)

Cerebral Venous Sinus Thrombosis Associated with Dutasteride Use
por: Choi, Bo Kyu, et al.
Publicado: (2020)

Is Dutasteride a Therapeutic Alternative for Amyotrophic Lateral Sclerosis?
por: Proaño, Belén, et al.
Publicado: (2022)

Intravesical aminophylline instillation as an alternative for balloon dilatation prior to semi-rigid ureteroscopic management of distal ureteral stones
por: Shabayek, M., et al.
Publicado: (2022)

Dutasteride: an evidence-based review of its clinical impact in the treatment of benign prostatic hyperplasia
por: Thomson, Andrew
Publicado: (2005)

Preparation, Characterization and Stability Study of Dutasteride Loaded Nanoemulsion for Treatment of Benign Prostatic Hypertrophy
por: Ali, Mohammad Sajid, et al.
Publicado: (2014)

A cost effective analysis of fixed-dose combination of dutasteride and tamsulosin compared with dutasteride monotherapy for benign prostatic hyperplasia in Nigeria: a middle income perspective; using an interactive Markov model
por: Udeh, Emeka I., et al.
Publicado: (2016)

RP-HPLC Method for the Estimation of Dutasteride in Tablet Dosage Form
por: Patel, Dipti B., et al.
Publicado: (2010)

LINCS Dataset-Based Repositioning of Dutasteride as an Anti-Neuroinflammation Agent
por: Luo, Dan, et al.
Publicado: (2021)

Effects of dutasteride and tamsulosin on penile morphology in a rodent model
por: Da Silva, Marcello H. A., et al.
Publicado: (2023)

Rates of prostate surgery and acute urinary retention for benign prostatic hyperplasia in men treated with dutasteride or finasteride
por: Kuiper, Josephina G., et al.
Publicado: (2016)

Does dutasteride reduce perioperative blood loss and postoperative complications after transurethral resection of the prostate?
por: Shanmugasundaram, R., et al.
Publicado: (2007)

Evaluation of bioequivalence of five 0.1 mg dutasteride capsules compared to one 0.5 mg dutasteride capsule: a randomized study in healthy male volunteers
por: Fossler, Michael J., et al.
Publicado: (2015)

Ovarian Stimulation in Patient-oriented Strategies Encompassing Individualised Oocyte Number-4 Category; Antagonist versus Short-agonist Protocols
por: Al-Hussaini, Tarek K., et al.
Publicado: (2023)

Ionic liquids IIIB
por: Rogers, Robin D, et al.
Publicado: (2005)

Controlled Release of Dutasteride from Biodegradable Microspheres: In Vitro and In Vivo Studies
por: Xie, Xiangyang, et al.
Publicado: (2014)

A population-based study of the risk of osteoporosis and fracture with dutasteride and finasteride
por: Antoniou, Tony, et al.
Publicado: (2018)

In Vitro and In Vivo Assessment of Metabolic Drug Interaction Potential of Dutasteride with Ketoconazole
por: Seo, Seong-Wook, et al.
Publicado: (2019)

Bone Health Risks Associated with Finasteride and Dutasteride Long-Term Use
por: Sirufo, Maria Maddalena, et al.
Publicado: (2021)

The Effect of Finasteride and Dutasteride on the Growth of WPE1-NA22 Prostate Cancer Xenografts in Nude Mice
por: Opoku-Acheampong, Alexander B., et al.
Publicado: (2012)

The efficacy and safety of dutasteride and finasteride in patients with benign prostatic hyperplasia: a systematic review and meta-analysis
por: Li, Yao, et al.
Publicado: (2022)

The neurobehavioral phenotype in mucopolysaccharidosis Type IIIB: An exploratory study
por: Shapiro, E., et al.
Publicado: (2016)

Effect of perioperative selective alpha-1 blockers in non-stented ureteroscopic laser lithotripsy for ureteric stones: a randomized controlled trial
por: Tawfeek, A.M., et al.
Publicado: (2020)

MRI findings in men on active surveillance for prostate cancer: does dutasteride make MRI visible lesions less conspicuous? Results from a placebo-controlled, randomised clinical trial
por: Giganti, Francesco, et al.
Publicado: (2017)

Genetic variations associated with response to dutasteride in the treatment of male subjects with androgenetic alopecia
por: Rhie, Arang, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_h220spjubqojmvptkhet8tu1th